|
|
||||||||
Departments of Biochemistry and Nutrition, University of Montreal, Montreal, Canada
Division of Nuclear Medicine, Massachusetts General Hospital, Boston, Massachusetts
Correspondence: For reprints contact: Henri Brunengraber, Research Center, Notre-Dame Hospital, Montreal, QC, H2L 4M1, Canada.
ABSTRACT
The metabolism of ß-methyl-[1-14C]heptadecanoic acid, a potential myocardial imaging agent, was investigated in perfused hearts and livers from rats. Hepatic uptake is
4.5 times greater than cardiac uptake. In the heart, 66% of ß-methyl-heptadecanoic acid metabolism occurs via omega-oxidation, 33% by esterification and <1% via alpha-oxidation. In contrast, 53% of hepatic metabolism of ß-methyl-heptadecanoic acid occurs via alpha-oxidation, 27% via omega-oxidation, and 20% via esterification. Perfusion of hearts and livers with concentrations of ß-methyl-heptadecanoic acid 100 to 1000 times greater than that used for myocardial imaging does not alter any of the physiological and biochemical parameters measured. In the perfused liver, 3-methyl-[1-14C]glutarate was identified as the principal hydrosoluble catabolite of ß-methyl-heptadecanoic acid.
This article has been cited by other articles:
![]() |
N. D. Oakes, A. Kjellstedt, G.-B. Forsberg, T. Clementz, G. Camejo, S. M. Furler, E. W. Kraegen, M. Ölwegård-Halvarsson, A. B. Jenkins, and B. Ljung Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer J. Lipid Res., June 1, 1999; 40(6): 1155 - 1169. [Abstract] [Full Text] |
||||
![]() |
Y. Yamane, N. Ishide, Y. Kagaya, D. Takeyama, N. Shiba, M. Chida, T. Nozaki, T. Takahashi, T. Ido, and K. Shirato Heterogeneous fatty acid uptake early after reperfusion in rat hearts Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H923 - H929. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |